Generalisierte Pustolose nach Covid-19-Impfung, bei einer Patientin unter Adalimumab-Therapie: Generalized pustulosis following Covid 19 vaccination in a patient in treatment with adalimumab
J Dtsch Dermatol Ges
.
2024 Feb;22(2):271-273.
doi: 10.1111/ddg.15278_g.
Authors
Inés Oteiza Rius
1
,
Ángela Estenaga
2
,
Javier Antoñanzas
1
,
Ana Morelló Vicente
1
,
María Laiño
2
,
Josune Mitxelena
2
,
Leyre Aguado Gil
1
Affiliations
1
Clínica Universidad de Navarra, Pamplona, Spanien.
2
Hospital Universitario de Navarra, Pamplona, Spanien.
PMID:
38361197
DOI:
10.1111/ddg.15278_g
No abstract available
Publication types
Letter
MeSH terms
Adalimumab / adverse effects
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
Treatment Outcome
Vaccination
Substances
Adalimumab
COVID-19 Vaccines